Skip to main content
. 2020 Jan 8;20(5):1384–1392. doi: 10.1111/ajt.15748

Table 2.

Basic characteristics of pediatric patients undergoing liver transplantation

  (n = 20)
Pretransplant characteristics
Indication for transplantation
Biliary atresia 9 (45%)
Congenital cholestasis 6 (30%)
Metabolic 4 (20%)
Hepatoblastoma 1 (5%)
PELD score 28 (28‐30)
Lab MELD score 15 (6‐22)
High urgency 3 (15%)
Previous portal vein thrombosis 2 (10%)
Hemoglobin, mmol/L 5.8 (4.7‐6.4)
Platelet count, 109/L 145 (98‐195)
Serum creatinine, µmol/L 21 (15‐37)
Serum bilirubin, µmol/L 213 (36‐355)
Aspartate aminotransferase, U/L 114 (75‐215)
Alanine transaminase, U/L 76 (48‐106)
International normalized ratio 1.4 (1.1‐1.8)
Donor characteristics
Gender, female 8 (40%)
Age, y 33 (23‐43)
Weight, kg 76 (65‐83)
Length, cm 174 (165‐182)
Donor type
Living donor 13 (65%)
Brain death 5 (25%)
Circulatory death 2 (10%)
Graft type
Left lateral segments 15 (75%)
Left lobe 1 (5%)
Full size 4 (20%)
Graft weight, g 316 (254‐413)
Graft/recipient weight ratio 2.3 (1.7‐3.4)
Surgical characteristics
Cold ischemia time, min 61 (47‐404)
Warm ischemia time, min 34 (29‐39)
Operation time, min 472 (426‐526)
Blood loss, mL/kg 67 (35‐116)
Blood transfusion, mL/kg 32 (13‐68)
Platelet transfusion, mL/kg 0 (0‐18)a
FFP transfusion, mL/kg 0 (0‐52)a
Fibrinogen, mg/kg 0 (0‐15)a

Data presented as median (interquartile range) or number (%) where appropriate. P value using two sample Mann‐Whitney U test and Pearson chi‐square tests.

Abbreviations: FFP, fresh frozen plasma; MELD score, model for end‐stage liver disease score; PELD score, pediatric end‐stage liver disease score; U/L, units per liter.

a

Ranges instead of interquartile range values are given.